{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:08:52Z","timestamp":1790662132830,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.trsl.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T17:05:18Z","timestamp":1678986318000},"page":"47-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease"],"prefix":"10.1016","volume":"258","author":[{"given":"Abdellah","family":"Tebani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Barbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dormond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Ducatez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Marret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-7270","authenticated-orcid":false,"given":"Soumeya","family":"Bekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2023.02.006_bib0001","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2023.02.006_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/biom11020271","article-title":"Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions","volume":"11","author":"Kok","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.trsl.2023.02.006_bib0003","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","article-title":"Anderson-Fabry disease: a multiorgan disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.trsl.2023.02.006_bib0004","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/hmg\/ddv291","article-title":"Lyso-Gb3 activates Notch1 in human podocytes","volume":"24","author":"Sanchez-Ni\u00f1o","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2023.02.006_bib0005","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2023.02.006_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trsl.2023.02.006_bib0007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2023.02.006_bib0008","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jimd.12167","article-title":"Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohort","volume":"43","author":"Nowak","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.trsl.2023.02.006_bib0009","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Mede"},{"key":"10.1016\/j.trsl.2023.02.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120985627","article-title":"Renal manifestations of Fabry disease: a narrative review","volume":"8","author":"Silva","year":"2021","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.trsl.2023.02.006_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.trsl.2023.02.006_bib0012","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2023.02.006_bib0013","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/tra.12587","article-title":"Mechanisms of lysosomal positioning and movement","volume":"19","author":"Cabukusta","year":"2018","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.trsl.2023.02.006_bib0014","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1242\/jcs.196287","article-title":"Mechanisms and functions of lysosome positioning","volume":"129","author":"Pu","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.trsl.2023.02.006_bib0015","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.bbadis.2019.03.009","article-title":"Lysosome motility and distribution: relevance in health and disease","volume":"1865","author":"Oyarz\u00fan","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.trsl.2023.02.006_bib0016","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/ijms17091555","article-title":"Omics-based strategies in precision medicine: toward a paradigm shift in inborn errors of metabolism investigations","volume":"17","author":"Tebani","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2023.02.006_bib0017","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1039\/c3mb25402j","article-title":"Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings","volume":"9","author":"Cigna","year":"2013","journal-title":"Molecular BioSystems"},{"key":"10.1016\/j.trsl.2023.02.006_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009098","article-title":"Elevated inflammatory plasma biomarkers in patients with Fabry disease: a critical link to heart failure with preserved ejection fraction","volume":"7","author":"Yogasundaram","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trsl.2023.02.006_bib0019","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1039\/C4MB00707G","article-title":"Early markers of Fabry disease revealed by proteomics","volume":"11","author":"Matafora","year":"2015","journal-title":"Mol BioSyst"},{"key":"10.1016\/j.trsl.2023.02.006_bib0020","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1021\/pr301200e","article-title":"The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patients","volume":"12","author":"Manwaring","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.trsl.2023.02.006_bib0021","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jmedgenet-2017-104704","article-title":"Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy","volume":"54","author":"Heo","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2023.02.006_bib0022","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1073\/pnas.0611315104","article-title":"Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities","volume":"104","author":"Moore","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2023.02.006_bib0023","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stemcr.2019.07.004","article-title":"A human stem cell model of Fabry disease implicates LIMP-2 accumulation in cardiomyocyte pathology","volume":"13","author":"Birket","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.trsl.2023.02.006_bib0024","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/cells8040327","article-title":"Generation of GLA-knockout human embryonic stem cell lines to model autophagic dysfunction and exosome secretion in fabry disease-associated hypertrophic cardiomyopathy","volume":"8","author":"Song","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2023.02.006_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ymgme.2018.11.005","article-title":"Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study","volume":"126","author":"Weidemann","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2023.02.006_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jmedgenet-2019-106030","article-title":"Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease","volume":"57","author":"Doykov","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2023.02.006_bib0027","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/jcm9051325","article-title":"A proteomics-based analysis reveals predictive biological patterns in Fabry disease","volume":"9","author":"Tebani","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.trsl.2023.02.006_bib0028","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2020.10.006","article-title":"Proteomics for the study of new biomarkers in Fabry disease: state of the art","volume":"132","author":"Rossi","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2023.02.006_bib0029","first-page":"1","article-title":"The tidyverse","volume":"1","author":"Wickham","year":"2017","journal-title":"R Package Ver"},{"key":"10.1016\/j.trsl.2023.02.006_bib0030","doi-asserted-by":"crossref","unstructured":"Wickham H, Chang W, Wickham MH. Package \u2018ggplot2\u2019. Create elegant data visualisations using the grammar of graphics version. 2016;2:1\u2013189.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"10.1016\/j.trsl.2023.02.006_bib0031","doi-asserted-by":"crossref","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. arXiv preprint arXiv:14065823. 2014.","DOI":"10.18637\/jss.v067.i01"},{"key":"10.1016\/j.trsl.2023.02.006_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v059.i09","article-title":"A kenward-roger approximation and parametric bootstrap methods for tests in linear mixed models\u2013the R package pbkrtest","volume":"59","author":"Halekoh","year":"2014","journal-title":"J Stat Softw"},{"key":"10.1016\/j.trsl.2023.02.006_bib0033","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Methodol"},{"key":"10.1016\/j.trsl.2023.02.006_bib0034","doi-asserted-by":"crossref","unstructured":"McInnes L, Healy J, Melville J. Umap: uniform manifold approximation and projection for dimension reduction. arXiv preprint arXiv:180203426. 2018.","DOI":"10.21105\/joss.00861"},{"key":"10.1016\/j.trsl.2023.02.006_bib0035","article-title":"CTD: an information-theoretic algorithm to interpret sets of metabolomic and transcriptomic perturbations in the context of graphical models","volume":"17","author":"Thistlethwaite","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.trsl.2023.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v077.i01","article-title":"ranger: a fast implementation of random forests for high dimensional data in C++ and R","volume":"77","author":"Wright","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.trsl.2023.02.006_bib0037","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0031-3203(96)00142-2","article-title":"The use of the area under the ROC curve in the evaluation of machine learning algorithms","volume":"30","author":"Bradley","year":"1997","journal-title":"Pattern Recognit"},{"key":"10.1016\/j.trsl.2023.02.006_bib0038","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.02.006_bib0039","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2023.02.006_bib0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"Consortium","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.trsl.2023.02.006_bib0041","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/cge.13497","article-title":"Hypermobile Ehlers-Danlos-like syndrome in Fabry disease","volume":"95","author":"Barbey","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.trsl.2023.02.006_bib0042","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurheartj\/ehp426","article-title":"Aortic remodelling in Fabry disease","volume":"31","author":"Barbey","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trsl.2023.02.006_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.703489","article-title":"Reconstruction of the cytokine signaling in lysosomal storage diseases by literature mining and network analysis","volume":"9","author":"Parolo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.trsl.2023.02.006_bib0044","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-018-29240-w","article-title":"Urine-derived cells: a promising diagnostic tool in Fabry disease patients","volume":"8","author":"Slaats","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2023.02.006_bib0045","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/01.ASN.0000121781.89599.16","article-title":"Signaling danger: toll-like receptors and their potential roles in kidney disease","volume":"15","author":"Anders","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2023.02.006_bib0046","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2023.02.006_bib0047","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trsl.2023.02.006_bib0048","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1111\/febs.15776","article-title":"A guide to the composition and functions of the extracellular matrix","volume":"288","author":"Karamanos","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.trsl.2023.02.006_bib0049","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/membranes10120406","article-title":"Lysosomal exocytosis: the extracellular role of an intracellular organelle","volume":"10","author":"Tancini","year":"2020","journal-title":"Membranes"},{"key":"10.1016\/j.trsl.2023.02.006_bib0050","doi-asserted-by":"crossref","first-page":"D1136","DOI":"10.1093\/nar\/gkz849","article-title":"MatrisomeDB: the ECM-protein knowledge database","volume":"48","author":"Shao","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2023.02.006_bib0051","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1038\/s41467-020-18148-7","article-title":"Integration of molecular profiles in a longitudinal wellness profiling cohort","volume":"11","author":"Tebani","year":"2020","journal-title":"Nat Commun"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:47:10Z","timestamp":1761828430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524423000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":51,"alternative-id":["S1931524423000385"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.02.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}